Literature DB >> 21937909

Alzheimer disease pathology in subjects without dementia in 2 studies of aging: the Nun Study and the Adult Changes in Thought Study.

Karen S SantaCruz1, Joshua A Sonnen, Maryam Kherad Pezhouh, Mark F Desrosiers, Peter T Nelson, Suzanne L Tyas.   

Abstract

Individuals with antemortem preservation of cognition who show autopsy evidence of at least moderate Alzheimer disease (AD) pathology suggest the possibility of brain reserve, that is, functional resistance to structural brain damage. This reserve would, however, only be relevant if the pathologic markers correlate well with dementia. Using data from the Nun Study (n = 498) and the Adult Changes in Thought (ACT) Study (n = 323), we show that Braak staging correlates strongly with dementia status. Moreover, participants with severe(Braak stage V-VI) AD pathology who remained not demented represent only 12% (Nun Study) and 8% (ACT study) of nondemented subjects. Comparison of these subjects to those who were demented revealed that the former group was often significantly memory-impaired despite not being classified as demented. Most of these nondemented participants showed only stage V neurofibrillary pathology and frontal tangle counts that were slightly lower than a comparable (Braak stage V) dementia group. In summary, these data indicate that, in individuals with AD-type pathology who do not meet criteria for dementia, neocortical neurofibrillary tangles are somewhat reduced and incipient cognitive decline is present. Our data provide a foundation for helping to define additional factors that may impair, or be protective of, cognition in older adults.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21937909      PMCID: PMC3445265          DOI: 10.1097/NEN.0b013e31822e8ae9

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  39 in total

1.  Simulated activities of daily living examination.

Authors:  A R Potvin; W W Tourtellotte; J S Dailey; J W Alberts; J E Walker; R W Pew; W G Henderson; D N Snyder
Journal:  Arch Phys Med Rehabil       Date:  1972-10       Impact factor: 3.966

2.  Dementia and Alzheimer disease incidence: a prospective cohort study.

Authors:  Walter A Kukull; Roger Higdon; James D Bowen; Wayne C McCormick; Linda Teri; Gerard D Schellenberg; Gerald van Belle; Lance Jolley; Eric B Larson
Journal:  Arch Neurol       Date:  2002-11

3.  Brain infarction and the clinical expression of Alzheimer disease. The Nun Study.

Authors:  D A Snowdon; L H Greiner; J A Mortimer; K P Riley; P A Greiner; W R Markesbery
Journal:  JAMA       Date:  1997-03-12       Impact factor: 56.272

4.  Aging and Alzheimer's disease: lessons from the Nun Study.

Authors:  D A Snowdon
Journal:  Gerontologist       Date:  1997-04

Review 5.  Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease.

Authors: 
Journal:  Neurobiol Aging       Date:  1997 Jul-Aug       Impact factor: 4.673

Review 6.  Neuropathological stageing of Alzheimer-related changes.

Authors:  H Braak; E Braak
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

7.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease.

Authors:  J C Morris; A Heyman; R C Mohs; J P Hughes; G van Belle; G Fillenbaum; E D Mellits; C Clark
Journal:  Neurology       Date:  1989-09       Impact factor: 9.910

8.  Linguistic ability in early life and cognitive function and Alzheimer's disease in late life. Findings from the Nun Study.

Authors:  D A Snowdon; S J Kemper; J A Mortimer; L H Greiner; D R Wekstein; W R Markesbery
Journal:  JAMA       Date:  1996-02-21       Impact factor: 56.272

9.  Correlations between mental state and quantitative neuropathology in the Vienna Longitudinal Study on Dementia.

Authors:  C Bancher; K Jellinger; H Lassmann; P Fischer; F Leblhuber
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1996       Impact factor: 5.270

10.  Cerebral amyloid deposition and diffuse plaques in "normal" aging: Evidence for presymptomatic and very mild Alzheimer's disease.

Authors:  J C Morris; M Storandt; D W McKeel; E H Rubin; J L Price; E A Grant; L Berg
Journal:  Neurology       Date:  1996-03       Impact factor: 9.910

View more
  32 in total

1.  Increased Hyaluronan and TSG-6 in Association with Neuropathologic Changes of Alzheimer's Disease.

Authors:  May J Reed; Mamatha Damodarasamy; Jasmine L Pathan; Christina K Chan; Charles Spiekerman; Thomas N Wight; William A Banks; Anthony J Day; Robert B Vernon; C Dirk Keene
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

Review 2.  The neuropathology and cerebrovascular mechanisms of dementia.

Authors:  Limor Raz; Janice Knoefel; Kiran Bhaskar
Journal:  J Cereb Blood Flow Metab       Date:  2016-01       Impact factor: 6.200

3.  The influence of tau, amyloid, alpha-synuclein, TDP-43, and vascular pathology in clinically normal elderly individuals.

Authors:  Alexandra M Wennberg; Jennifer L Whitwell; Nirubol Tosakulwong; Stephen D Weigand; Melissa E Murray; Mary M Machulda; Leonard Petrucelli; Michelle M Mielke; Clifford R Jack; David S Knopman; Joseph E Parisi; Ronald C Petersen; Dennis W Dickson; Keith A Josephs
Journal:  Neurobiol Aging       Date:  2019-01-21       Impact factor: 4.673

Review 4.  On the issue of transmissibility of Alzheimer disease: a critical review.

Authors:  Christian Schmidt; André Karch; Carsten Korth; Inga Zerr
Journal:  Prion       Date:  2012-10-10       Impact factor: 3.931

5.  Alzheimer's disease neuropathology may not predict functional impairment in HIV: a report of two individuals.

Authors:  Susan Morgello; Michelle Jacobs; Jacinta Murray; Desiree Byrd; Eric Neibart; Letty Mintz; Gregory Meloni; Christina Chon; John Crary
Journal:  J Neurovirol       Date:  2018-08-09       Impact factor: 2.643

6.  Antemortem Prediction of Braak Stage.

Authors:  Jesper O E Carlson; Margaret Gatz; Nancy L Pedersen; Caroline Graff; Inger Nennesmo; Anna-Karin Lindström; Lotte Gerritsen
Journal:  J Neuropathol Exp Neurol       Date:  2015-11       Impact factor: 3.685

7.  Florbetapir positron emission tomography and cerebrospinal fluid biomarkers.

Authors:  Ann Hake; Paula T Trzepacz; Shufang Wang; Peng Yu; Michael Case; Helen Hochstetler; Michael M Witte; Elisabeth K Degenhardt; Robert A Dean
Journal:  Alzheimers Dement       Date:  2015-04-24       Impact factor: 21.566

Review 8.  Does bilingualism contribute to cognitive reserve? Cognitive and neural perspectives.

Authors:  Edmarie Guzmán-Vélez; Daniel Tranel
Journal:  Neuropsychology       Date:  2014-06-16       Impact factor: 3.295

Review 9.  Non-Demented Individuals with Alzheimer's Disease Neuropathology: Resistance to Cognitive Decline May Reveal New Treatment Strategies.

Authors:  Olga Zolochevska; Giulio Taglialatela
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

10.  Relation of neuropathology to cognition in persons without cognitive impairment.

Authors:  David A Bennett; Robert S Wilson; Patricia A Boyle; Aron S Buchman; Julie A Schneider
Journal:  Ann Neurol       Date:  2012-10       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.